Just been watching cnbc and although there was no mention of MSB, my confidence in where we are was boosted by Dr Scott Gottlieb reiterating that the more data / patients the better and that because of an abundance of publicised treatment options - the more promising placebo trials have struggled to get their numbers... so, we are on the right track and the waiting game continues - but we close.
Just been watching cnbc and although there was no mention of...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.12 |
Change
0.015(1.36%) |
Mkt cap ! $1.278B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $7.169M | 6.411M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 7296 | $1.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.12 | 43068 | 1 |
View Market Depth
| Last trade - 16.10pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |